News

 

Open access agreement for Germany

Authors from more than 750 German institutions will be able to publish open access for free with CVIR Endovascular from August 2020. For more details, please visit the Springer website.

Make sure to read the Author Guide before submitting your paper to CVIR Endovascular.

Click the button below to read the list of eligible institutions that are included in the agreement.

 

Download
Springer Nature: List of eligible institutions
Springer Nature_DEAL_eligible_institutio
Microsoft Excel Table 38.8 KB

 

15% APC discount for CIRSE Members

CVIR Endovascular is the new multidisciplinary open access journal of CIRSE. To celebrate its success and to support publishing in the journal for as many CIRSE researchers as possible, CIRSE now offers a 15% discount on the article processing charges (APC)* for CVIR Endovascular to corresponding authors who are CIRSE members in good standing. In order to apply for this discount, please contact CVIR Endovascular’s editorial team at info@cvirendovascular.org before submitting your manuscript.
Please note that the CIRSE discount cannot be combined with an institutional discount
, or used for already published articles.

 

*CVIR Endovascular currently levies an APC of £990.00/$1390.00/€1060.00 for each article accepted for publication, plus VAT or local taxes where applicable.  

 

 

Congratulations to Prof. Jim A. Reekers

Congratulations to Prof Jim Reekers, CVIR Endovascular Editor-in-Chief and CIRSE's former president for receiving the ESR Gold Medal at ECR 2020 in recognition of his achievements in the field of IR, which we hope will increase the visibility of IR and the importance of endovascular procedures.

 

 

CVIR Endovascular now indexed in PubMed Central and PubMed

We are pleased to announce that CVIR Endovascular is now indexed in PubMed Central (PMC) / PubMed; two prestigious journal indexing and abstracting services and databases from the U.S. National Institutes of Health's National Library of Medicine (NIH/NLM).

 

This means that the full texts of all articles published in the journal are now available on PMC and the abstracts and citations are available on PubMed. This achievement reflects the growing success of the journal, its high-quality scientific articles, and the diversity and excellence of the editorial board, reviewers and authors. Indexing provides greater exposure and scientific validation for the journal and offers greater discoverability and visibility to our authors.

 

With its acceptance, CVIR Endovascular joins the league of other prestigious global medical journals who use the PubMed and PMC platforms to disseminate their work to millions of readers around the world who rely on the integrity of the NLM and NIH who curate these indexing services following intense scrutiny of the scientific, editorial and technical quality of its articles.

 

 

APC waiver for Letters to the Editor

Open access also means open discussion. Have your say and contribute to scientific discussion on endovascular treatments by submitting a Letter to the Editor critiquing a paper already published in CVIR Endovascular.

APC waivers available for this article type - contact info@cvirendovascular.org for details!

 

 

Consent for publication

Please note that all case reports are presenting individual patient data and therefore authors need to state that they have a written statement from the patient(s) that he/she gives informed consent for publication. Read more on editorial policies here.

 

We encourage authors to use the below template for the Consent for Publication statement, which has to be included as part of the Ethics Declarations section:

 “Written informed consent was obtained from the patient for publication of this case report and any accompanying images.”

In the event that your institution does not have an appropriate Consent for Publication form that you can use, please get in touch with us at
info@cvirendovascular.org

 

 

Reduced price for open access charges

CVIR Endovascular reduced the prices for all authors who submit to the journal and get their papers accepted for publishing. As of now on, article processing charges will be only €1,060/£990/$1,390 (plus VAT or local taxes where applicable).

 

 

Webinar on how to review by Prof. Jim Reekers

Peer review is a good opportunity for early career researchers to play a role in the research community and gain valuable experience to help improve your own research writing. If you would like to get involved in peer review and are looking for tips on how to deliver a great review for CVIR Endovascular, we invite you to watch the new webinar produced by Prof. Jim Reekers, Editor-in-Chief.

 

 

Call for papers: review articles

Would you like to report on a specialized topic of your interest addressing a specific question through a systematic assessment of research relevant to field of endovascular treatment and procedures? If you need funding for your open access fee, contact Prof. Jim Reekers with your proposal at info@cvirendovascular.org and ask for a waiver!

 

 

Direct transfer of good papers from CVIR to CVIR Endovascular!

Good papers submitted to CVIR and not accepted due to CVIR's limited page budget will be automatically transferred to CVIR Endovascular for consideration.

CVIR Endovascular is an online only journal and has no space limit.

 

CVIR Endovascular at CIRSE 2019

Thank you to all our readers, authors and reviewers who visited the booth during the "Meet & Greet" sessions, and to those who participated in the "Solve the Case" competition (winners pictured below) for making CIRSE 2019 a great congress for CVIR Endovascular!

 


CVIR Endovascular at ET 2019

During this year's European Conference on Embolotherapy (ET), Jim Reekers, CVIR Endovascular Editor-in-Chief, introduced the "Meet & Greet the Editor-in-Chief" sessions at the journal's booth, as a way to raise awareness of the journal.

 

Having opened for its first submissions in 2017, CVIR Endovascular is the fastest-growing IR endovascular journal, boasting continuously increasing submission rates and a high number of article accesses from all corners of the globe.

 

Thank you for all interested authors and reviewers that stopped by the booth at ET 2019 for a chat with the Editor-in-Chief.